X0303 4 2009-05-12 0 0000930184 VALEANT PHARMACEUTICALS INTERNATIONAL VRX 0001418814 ValueAct Holdings, L.P. 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001418812 VA Partners I, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001351069 ValueAct Capital Management, L.P. 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001351073 ValueAct Capital Management, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001418813 ValueAct Holdings GP, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 Common Stock, par value $.01 per share 2009-05-12 4 P 0 60000 19.81 A 14938814 I See footnote Common Stock, par value $.01 per share 2009-05-12 4 P 0 90000 19.83 A 15028814 I See footnote Common Stock, par value $.01 per share 2009-05-12 4 P 0 100000 19.85 A 15128814 I See footnote Common Stock, par value $.01 per share 2009-05-12 4 P 0 68115 19.85 A 15196929 I See footnote Common Stock, par value $.01 per share 2009-05-13 4 P 0 80000 19.86 A 15276929 I See footnote Common Stock, par value $.01 per share 2009-05-13 4 P 0 125000 19.76 A 15401929 I See footnote Common Stock, par value $.01 per share 2009-05-13 4 P 0 75000 19.67 A 15476929 I See footnote Common Stock, par value $.01 per share 2009-05-14 4 P 0 100000 19.78 A 15576929 I See footnote Common Stock, par value $.01 per share 2009-05-14 4 P 0 100000 19.56 A 15676929 I See footnote Common Stock, par value $.01 per share 2009-05-14 4 P 0 100000 19.54 A 15776929 I See footnote Securities reported are directly beneficially owned by ValueAct Capital Master Fund LP & may be deemed indirectly beneficially owned by (i) VA Partners I LLC as General Partner ("GP") of ValueAct Capital Master Fund LP (ii) ValueAct Capital Management LP as manager of ValueAct Capital Master Fund LP (iii) ValueAct Capital Management LLC as GP of ValueAct Capital Management LP (iv) ValueAct Holdings LP as sole owner of the limited partnership interests of ValueAct Capital Management LP & the membership interests of ValueAct Capital Management LLC & as majority owner of the membership interests of VA Partners I LLC & (v) ValueAct Holdings GP LLC as GP of ValueAct Holdings LP. Reporting persons disclaim beneficial ownership of reported securities except to the extent of pecuniary interest therein & this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Sec 16 of Securities Exchange Act of 1934 as amended or any other purpose The reporting persons herein may be deemed to be members of a "group" for purposes of the Securities Exchange Act of 1934, as amended. Each peporting person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by such reporting person. This report shall not be deemed an admission that such reporting person is a member of a group or the beneficial owner of any securities not directly owned by such reporting person. Joint Filer Information: Name: ValueAct Capital Master Fund, L.P. Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: ValueAct Holdings, L.P. Issuer and Ticker: Valeant Pharmaceuticals International (VRX) Date of Event Requiring Statement: 05/12/2009 Name: VA Partners I, LLC Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: ValueAct Holdings, L.P. Issuer and Ticker: Valeant Pharmaceuticals International (VRX) Date of Event Requiring Statement: 05/12/2009 Name: ValueAct Capital Management, L.P. Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: ValueAct Holdings, L.P. Issuer and Ticker: Valeant Pharmaceuticals International (VRX) Date of Event Requiring Statement: 05/12/2009 Name: ValueAct Capital Management, LLC Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: ValueAct Holdings, L.P. Issuer and Ticker: Valeant Pharmaceuticals International (VRX) Date of Event Requiring Statement: 05/12/2009 Name: ValueAct Holdings GP, LLC Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: ValueAct Holdings, L.P. Issuer and Ticker: Valeant Pharmaceuticals International (VRX) Date of Event Requiring Statement: 05/12/2009 VALUEACT HOLDINGS, L.P., By: VALUEACT HOLDINGS GP, LLC, its General Partner, By:/s/ George F. Hamel. Jr., Chief Operating Officer 2009-05-14 VALUEACT CAPITAL MASTER FUND, L.P., By: VA PARTNERS I, LLC, its General Partner, By:/s/ George F. Hamel. Jr., Chief Operating Officer 2009-05-14 VA PARTNERS I, LLC, By:/s/ George F. Hamel. Jr., Chief Operating Officer 2009-05-14 VALUEACT CAPITAL MANAGEMENT, L.P., By: VALUEACT CAPITAL MANAGEMENT, LLC, its General Partner, By:/s/ George F. Hamel. Jr., Chief Operating Officer 2009-05-14 VALUEACT CAPITAL MANAGEMENT, LLC, By:/s/ George F. Hamel. Jr., Chief Operating Officer 2009-05-14 VALUEACT HOLDINGS GP, LLC, By:/s/ George F. Hamel. Jr., Chief Operating Officer 2009-05-14